Alpha 2-adrenoceptor agonists in the treatment of hypertension
Kaplan, N.M.
Journal of Cardiovascular Pharmacology 7(Suppl 8): S64-S66
1985
ISSN/ISBN: 0160-2446 PMID: 2417050 Document Number: 256115
Alpha 2-adrenoceptor agonists are effective antihypertensive drugs that may provide particular advantages in the treatment of many types of patients. Of those now available, guanabenz has been shown to lower serum cholesterol concentration and not to cause sodium and water retention, offering additional protection against some of the metabolic side effects often seen with diuretics and beta-blockers.
Document emailed within 1 workday
Related Documents
Dollery, C.T. 1976: Centrally acting alpha-adrenoceptor agonists in hypertension: mechanisms and their role in therapy Australian and New Zealand Journal of Medicine 6(3): 88-94Schmidt-Oechtering, G.U.; Becker, K. 1992: Old and new alpha 2-adrenoceptor agonists. 1. Xylazine and medetomidine Tierarztliche Praxis 20(5): 447-458
Angel, I.; Bidet, S.; Langer, S.Z. 1988: Pharmacological characterization of the hyperglycemia induced by alpha-2 adrenoceptor agonists Journal of Pharmacology and Experimental Therapeutics 246(3): 1098-1103
Ruffolo, R.R.; Turowski, B.S.; Patil, P.N. 1977: Lack of cross-desensitization between structurally dissimilar alpha-adrenoceptor agonists Journal of Pharmacy and Pharmacology 29(6): 378-380
Svensson, T.H. 1987: Stress, central neurotransmitters, and the mechanism of action of alpha 2-adrenoceptor agonists Journal of Cardiovascular Pharmacology 10(Suppl 12): S88-S92
Blandford, D.E.; Smyth, D.D. 1990: Role of vasopressin in response to intrarenal infusions of alpha-2 adrenoceptor agonists Journal of Pharmacology and Experimental Therapeutics 255(1): 264-270
Tabrizchi, R.; Triggle, C.R. 1992: The interrelationship between the effects of captopril and nifedipine on pressor responses elicited by selective alpha-adrenoceptor agonists in the pithed rat preparation Journal of Cardiovascular Pharmacology 19(4): 562-567
Wiśniewska, R.J. 1998: Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A Polish Journal of Pharmacology 50(3): 203-212
Donello, J.E.; Padillo, E.U.; Webster, M.L.; Wheeler, L.A.; Gil, D.W. 2001: Alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia Journal of Pharmacology and Experimental Therapeutics 296(1): 216-223
Martin, D.J.; Lluel, P.; Guillot, E.; Coste, A.; Jammes, D.; Angel, I. 1997: Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists Journal of Pharmacology and Experimental Therapeutics 282(1): 228-235
Shi, C.Z.; Li, X.M.; Liu, Y.; Zhang, J.T. 1990: Application of mouse tail artery for the study of alpha adrenoceptor agonists and antagonists and calcium antagonists Yao Xue Xue Bao 25(3): 223-226
Stokes, G.S.; Marwood, J.F. 1984: Review of the use of alpha-adrenoceptor antagonists in hypertension Methods and Findings in Experimental and Clinical Pharmacology 6(4): 197-204
Weetman, D.F.; Jahn, U.; Ismail, S.; Chadwick, M.A.; Coates, J.; Lawson, K.; Turner, N.; Thiele, K. 1983: Sgd 101/75: a sympathomimetic that can be used to identify a new subtype of alpha-adrenoceptor, the alpha 1s-adrenoceptor Methods and Findings in Experimental and Clinical Pharmacology 5(7): 425-434
1976: Centrally acting alpha-agonists. Mechanisms and their role in the therapy of essential hypertension Australian and New Zealand Journal of Medicine 6(3): 98-101
Sanders, R.D.; Maze, M. 2007: Alpha2-adrenoceptor agonists Current Opinion in Investigational Drugs 8(1): 25-33
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Spadari, R.C.; De-Moraes, S. 1987: Aging and rat pacemaker sensitivity to beta-adrenoceptor agonists Brazilian Journal of Medical and Biological Research 20(5): 591-594
Vassilev, P.P. 1995: Beta-Adrenoceptor agonists-induced desensitization in rat trachea Acta Physiologica et Pharmacologica Bulgarica 21(3): 57-62
Canepa-Anson, R.; Dawson, J.R.; Frankl, W.S.; Kuan, P.; Sutton, G.C.; Reuben, S.; Poole-Wilson, P.A. 1982: Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias European Heart Journal 3 Suppl D: 129-134
Dawson, J.R.; Bayliss, J.; Norell, M.S.; Canepa-Anson, R.; Kuan, P.; Reuben, S.; Poole-Wilson, P.A.; Sutton, G.C. 1982: Clinical studies with beta 2 adrenoceptor agonists in heart failure European Heart Journal 3 Suppl D: 135-141